Decreased use of clonidine following treatment with atomoxetine in children with ADHD

Journal of Clinical Psychopharmacology

Volumn 26, Issue 4, 2006, Pages 389-395

  Johnston, Joseph A ^a   Ye, Wenyu ^a   Van Brunt, David L ^a   Pohl, Gerhardt ^a   Sumner, Calvin R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; CENTRAL STIMULANT AGENT; CLONIDINE;

ADOLESCENT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG SUBSTITUTION; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPPOSITIONAL DEFIANT DISORDER; PRESCRIPTION; PRIORITY JOURNAL; SLEEP DISORDER; TIC; UNITED STATES;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; CLONIDINE; COHORT STUDIES; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; PROPYLAMINES; TREATMENT OUTCOME;

EID: 33746902722     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000227697.41623.6d     Document Type: Article

References (31)

1. Lowe TL, Cohen DJ, Detlor J, et al. Stimulant medications precipitate Tourette's syndrome. JAMA. 1982;247(8):1168-1169.
2. Meyerhoff JL, Snyder SH. Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient. Psychopharmacologia. 1973;29(3):211-220.
3. Ahmann PA, Waltonen SJ, Olson KA, et al. Placebo-controlled evaluation of Ritalin side effects. Pediatrics. 1993;91:1101-1106.
4. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics. 1997;100:662-666.
5. Swanson JM, Flockhart D, Udrea D, et al. ADHD Clonidine in the treatment of ADHD: questions about safety and efficacy. J Child Adolesc Psychopharmacol. 1995;5:301-304.
6. Popper CW. Pharmacological alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;3:605-646.
7. Popper CW. Combining methylphenidate and clonidine: pharmacologic questions and news reports about sudden death. J Child Adolesc Psychopharmacol. 1995;5:157-166.
8. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Adolesc Psychiatry. 1985;24:617-629.
9. Steingard R, Biederman J, Spencer T, et al. Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 1993;32:350-353.
10. Prince JB, Wilens TE, Biederman J, et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35:599-605.
11. Boehringer Ingelheim Pharmaceuticals, Inc. Catapres-TTS (clonidine) package insert. Ridgefield, CT; 2003.
12. Cantwell DP, Swanson J, Connor DF. Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiatry. 1997;36:539-544.
13. Dawson PM, Zanden JA, Werkman SL, et al. Cardiac dysrhythmia with the use of clonidine in explosive disorder. DICP. 1989;23:465-466.
14. Chandran KS. ECG and clonidine [letter]. J Am Acad Child Adolesc Psychiatry. 1994;33:1351-1352.
15. Kofoed L, Tadepalli G, Oesterheld JR, et al. Case series: clonidine has no systematic effects on PR or QTc intervals in children. J Am Acad Child Adolesc Psychiatry. 1999;38:1193-1196.
16. Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108:e83.
17. Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002;159:1896-1901.
18. Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005;65:1941-1949.
19. Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry. 2002;63(suppl 12):50-55.
20. Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004;114:e1-e8.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
22. Greenhill L, Anich JP, Goetz R, et al. Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity. Sleep. 1983;6:91-101.
23. Trommer BL, Hoeppner JB, Rosenberg RS, et al. Sleep disturbance in children with attention deficit disorder. Ann Neurol. 1988;24:322.
24. Corkum P, Tannock R, Moldofsky H. Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1998;37:637-646.
25. Stein MA, Blondis TA, Schnitzler ER, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics. 1996;98:748-756.
26. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics. 1997;100:662-666.
27. Stein MA, Sarampote CS, Waldman ID, et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2003;112:e404-e413.
28. Schachar RJ, Tannock R, Cunningham C, et al. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry. 1997;36:754-763.
29. Owens JA, Rosen CL, Mindell JA. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics. 2003;111:e628-e635.
30. Rosen CL, Owens JA, Scher MS, et al. Pharmacotherapy for pediatric sleep disturbances: current patterns of use and target population for controlled clinical trials. Curr Ther Res. 2002;63(suppl B):B53-B66.
31. Peabody JW, Luck J, Jain S, et al. Assessing the accuracy of administrative data in health information systems. Med Care. 2004;42:1066-1072.